CLB - Core Laboratories N.V.

NYSE - NYSE Delayed Price. Currency in USD
32.68
-0.08 (-0.24%)
At close: 4:01PM EST
Stock chart is not supported by your current browser
Previous Close32.76
Open32.95
Bid32.03 x 1800
Ask32.57 x 1000
Day's Range32.50 - 33.13
52 Week Range32.50 - 75.63
Volume545,640
Avg. Volume697,314
Market Cap1.452B
Beta (5Y Monthly)1.75
PE Ratio (TTM)14.30
EPS (TTM)2.29
Earnings DateApr. 21, 2020 - Apr. 26, 2020
Forward Dividend & Yield1.00 (3.05%)
Ex-Dividend DateJan. 22, 2020
1y Target Est41.81
  • Thomson Reuters StreetEvents

    Edited Transcript of CLB earnings conference call or presentation 30-Jan-20 1:30pm GMT

    Q4 2019 Core Laboratories NV Earnings Call

  • Lawrence Bruno Is The COO, President & Supervisory Director of Core Laboratories N.V. (NYSE:CLB) And They Just Spent US$105k On Shares
    Simply Wall St.

    Lawrence Bruno Is The COO, President & Supervisory Director of Core Laboratories N.V. (NYSE:CLB) And They Just Spent US$105k On Shares

    Potential Core Laboratories N.V. (NYSE:CLB) shareholders may wish to note that the COO, President & Supervisory...

  • Core Labs' (CLB) Q4 Earnings Meet, Sales Miss Estimates
    Zacks

    Core Labs' (CLB) Q4 Earnings Meet, Sales Miss Estimates

    Core Laboratories (CLB) Q4 results benefit from cost-control initiatives and operational efficiencies.

  • Core Laboratories (CLB) Matches Q4 Earnings Estimates
    Zacks

    Core Laboratories (CLB) Matches Q4 Earnings Estimates

    Core Laboratories (CLB) delivered earnings and revenue surprises of 0.00% and 1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Earnings Preview: Core Laboratories (CLB) Q4 Earnings Expected to Decline
    Zacks

    Earnings Preview: Core Laboratories (CLB) Q4 Earnings Expected to Decline

    Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • New Strong Sell Stocks for January 16th
    Zacks

    New Strong Sell Stocks for January 16th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today

  • New Strong Sell Stocks for January 15th
    Zacks

    New Strong Sell Stocks for January 15th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today

  • What Does Core Laboratories N.V.'s (NYSE:CLB) P/E Ratio Tell You?
    Simply Wall St.

    What Does Core Laboratories N.V.'s (NYSE:CLB) P/E Ratio Tell You?

    The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll apply a basic P/E...

  • Oil & Gas Stock Roundup: ExxonMobil's Q4 Update, Core Labs' Dividend Cut & More
    Zacks

    Oil & Gas Stock Roundup: ExxonMobil's Q4 Update, Core Labs' Dividend Cut & More

    Supermajor ExxonMobil (XOM) issued an update on its upcoming fourth-quarter earnings. Meanwhile, Core Labs (CLB) slashed its dividend by 55% and lowered fourth-quarter guidance.

  • Core Labs (CLB) Cuts Quarterly Dividend, Revises Q4 Guidance
    Zacks

    Core Labs (CLB) Cuts Quarterly Dividend, Revises Q4 Guidance

    Core Labs (CLB) initiates a preliminary view for the first quarter of 2020 wherein it expects its quarterly revenues within $159-$164 million and earnings per share in the 39-41 cents range.

  • Oilfield Services Ends the 2010s With a Bang and a Whimper
    Bloomberg

    Oilfield Services Ends the 2010s With a Bang and a Whimper

    (Bloomberg Opinion) -- “When does it end?” is a perfectly reasonable question for New Year’s Eve. And in the case of anyone still holding onto oilfield services stocks, it is more than rhetorical.Core Laboratories NV, which offers services to enhance output from oilfields, dropped the ball early on Thursday evening, or New Year’s Eve Eve if you will. It cut guidance for the quarter just about to end, issued underwhelming guidance for the quarter about to begin and, to cap it off, slashed its dividend by more than half. The latter was declared “sacrosanct” by management only two months ago — which, in hindsight, is one of those overwrought words that should set alarm bells ringing. Throw in Tuesday’s pre-drinking trading volumes, and the stock looks set to see out 2019 with a bang (not the good kind).The ostensible reason for the sudden about-face is sluggish activity in international markets, which were hoped to offset the drag from the slowdown in U.S. fracking. The underlying reason is one that blends the oil business with New Year’s Eve seamlessly: the triumph of hope over experience.It is telling that Core Labs last raised its dividend in the second quarter of 2016, just after oil prices had bottomed out below $30 a barrel. At the time, the company anticipated a “V-shaped” recovery in commodity markets. But the seams were splitting. Shareholder equity had already dipped further into deficit in the first quarter of that year as dividends outpaced earnings. And a month after raising the dividend, Core Labs sold another $175 million of stock to help pay down its revolver.In short, the company was paying a pre-crash dividend on post-crash cash flows in the hope that the inevitable swing up in oil prices would make it all balance out. Core Labs was certainly not alone in this thinking. But the oil market’s “V” turned out to be more a series of w’s.Consequently, net debt to Ebitda has almost doubled since the middle of 2018, hitting 2.8 times at the end of September. By then, analysts were speculating about whether Core Labs would have to cut its dividend, just as they were back in early 2016. Yet analysts also remained bullish, with 16 recommending holding or buying the stock and just one advocating selling before Monday evening’s announcement.In some respects, affinity for Core Labs is understandable. Capital intensity is low, and the company generates free cash flow consistently. Executive pay is also tied mostly to financial metrics. And, of course, Core Labs has striven to maintain the dividend.The problem is that, in key respects, these perceived strengths rest on an anachronism. Compensation, while tied to financial performance, also remains tied overwhelmingly to relative rather than absolute performance — which doesn’t do much for shareholders in an energy sector this troubled. Meanwhile, sticking with a dividend is laudable only if it isn’t hollowing out your balance sheet and, as the risk premium rises, the stock price it ostensibly supports.Core Labs has finally done the right thing but will inevitably pay a heavy price, at least in the short term. Beware oilfield services stocks as a whole, however, which are up almost a fifth this month on the back of a 10% rally in oil prices. Core Labs’ capitulation suggests the sector is about to undergo another round of warnings and cuts to guidance and forecasts as expectations of recovery get pushed out again.One silver lining (it is New Year’s Eve, after all) is that the oilfield services sector’s continuing woes indicate that recently-discovered discipline on the part of exploration and production companies may be sticking. This, in turn, would start to restore resilience to the contractors’ customer base and, by reining in U.S. supply, offer support to oil prices.If that sounds like a lot of ifs and maybes strung together, that’s because it is. Core Labs’ cut closes out a decade in which the oil business in general stuck with a growth model relying implicitly on higher oil prices filling gaps in cash flow — while that same dash for growth undermined those oil prices. As most of us know from bitter experience, a truly happy new year begins with a little restraint beforehand.To contact the author of this story: Liam Denning at ldenning1@bloomberg.netTo contact the editor responsible for this story: Mark Gongloff at mgongloff1@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Liam Denning is a Bloomberg Opinion columnist covering energy, mining and commodities. He previously was editor of the Wall Street Journal's Heard on the Street column and wrote for the Financial Times' Lex column. He was also an investment banker.For more articles like this, please visit us at bloomberg.com/opinion©2020 Bloomberg L.P.

  • Can Core Laboratories N.V. (NYSE:CLB) Maintain Its Strong Returns?
    Simply Wall St.

    Can Core Laboratories N.V. (NYSE:CLB) Maintain Its Strong Returns?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Something To Consider Before Buying Core Laboratories N.V. (NYSE:CLB) For The 4.7% Dividend
    Simply Wall St.

    Something To Consider Before Buying Core Laboratories N.V. (NYSE:CLB) For The 4.7% Dividend

    Is Core Laboratories N.V. (NYSE:CLB) a good dividend stock? How can we tell? Dividend paying companies with growing...

  • Why Is Core Laboratories (CLB) Up 3.6% Since Last Earnings Report?
    Zacks

    Why Is Core Laboratories (CLB) Up 3.6% Since Last Earnings Report?

    Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Introducing Core Laboratories (NYSE:CLB), The Stock That Slid 67% In The Last Five Years
    Simply Wall St.

    Introducing Core Laboratories (NYSE:CLB), The Stock That Slid 67% In The Last Five Years

    Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed...

  • Thomson Reuters StreetEvents

    Edited Transcript of CLB earnings conference call or presentation 24-Oct-19 12:30pm GMT

    Q3 2019 Core Laboratories NV Earnings Call

  • Core Laboratories (CLB) Q3 Earnings and Sales Beat Estimates
    Zacks

    Core Laboratories (CLB) Q3 Earnings and Sales Beat Estimates

    Better crude oil market fundamentals are likely to scale up international activities, thereby boosting the prospects of Core Laboratories' (CLB) Reservoir Description unit.

  • SLB & HAL Q3 Earnings Review: International Operations Strong
    Zacks

    SLB & HAL Q3 Earnings Review: International Operations Strong

    Significant exposure to profitable international markets have helped Schlumberger (SLB) and Halliburton (HAL) combat weak North American operations in third-quarter 2019.

  • What Lies Ahead for Oilfield Service in Q3 Earnings?
    Zacks

    What Lies Ahead for Oilfield Service in Q3 Earnings?

    Although weak oil pricing and conservative capital spending by US explorers might have acted as headwinds in Q3, rising rig count in international market may have lent support to oilfield service.

  • Core Laboratories (CLB) Expected to Beat Earnings Estimates: Should You Buy?
    Zacks

    Core Laboratories (CLB) Expected to Beat Earnings Estimates: Should You Buy?

    Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Dividend Investors: Don't Be Too Quick To Buy Core Laboratories N.V. (NYSE:CLB) For Its Upcoming Dividend
    Simply Wall St.

    Dividend Investors: Don't Be Too Quick To Buy Core Laboratories N.V. (NYSE:CLB) For Its Upcoming Dividend

    It looks like Core Laboratories N.V. (NYSE:CLB) is about to go ex-dividend in the next 3 days. You can purchase shares...

  • Should You Like Core Laboratories N.V.’s (NYSE:CLB) High Return On Capital Employed?
    Simply Wall St.

    Should You Like Core Laboratories N.V.’s (NYSE:CLB) High Return On Capital Employed?

    Today we are going to look at Core Laboratories N.V. (NYSE:CLB) to see whether it might be an attractive investment...

  • Morningstar

    Core Lab Has the Strongest Moat in the Industry

    For one, it possesses the strongest economic moat across our entire oilfield services coverage. The company's foundational core analysis business in the reservoir description segment, in particular, has been virtually unchallenged over the past three decades. The downturn in oil and gas activity beginning in late 2014 has depressed financial results for most oilfield services companies, and Core Lab hasn't fully escaped the effects.

  • Are Insiders Buying Core Laboratories N.V. (NYSE:CLB) Stock?
    Simply Wall St.

    Are Insiders Buying Core Laboratories N.V. (NYSE:CLB) Stock?

    We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...

  • 3 Top Energy Stocks to Buy in September
    Motley Fool

    3 Top Energy Stocks to Buy in September

    Investors looking at the sector should check out these players in oilfield services, solar panels, and renewable energy production.